Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
1.
Philos Trans R Soc Lond B Biol Sci ; 366(1579): 2743-7, 2011 Oct 12.
Artigo em Inglês | MEDLINE | ID: mdl-21893535

RESUMO

The Global Alliance for Vaccines and Immunization (GAVI), now 10 years old, was established as a successful and innovative public-private partnership to deal with a fundamental inequity. The poorest children in the poorest parts of the world were being denied access to life-saving vaccines simply on the basis of cost. GAVI has been successful in mobilizing significant funding from donors and through innovative financing instruments, immunizing large numbers of children. GAVI has been less successful, at least in the time frames first envisaged, at quickly reducing the prices of new and under-used vaccines to levels affordable by the poorest countries. Vaccines remain some of the most cost effective of public health interventions. As GAVI seeks to introduce a new set of vaccines to tackle major killers such as pneumonia and diarrhoea, and emerging threats such as cervical cancer, it needs to raise significant additional funds. There is no single solution. Multiple and new instruments will be required to raise finance both globally and at the country level, and also to incentivize industry and others to provide vaccines at affordable prices to the poorest countries.


Assuntos
Atenção à Saúde/organização & administração , Programas de Imunização/organização & administração , Pobreza/economia , Parcerias Público-Privadas/organização & administração , Criança , Custos de Medicamentos , Indústria Farmacêutica/economia , Saúde Global/economia , Humanos , Programas de Imunização/economia , Saúde Pública/economia , Parcerias Público-Privadas/economia , Vacinação/economia , Vacinação/métodos , Vacinas/economia
2.
Lancet ; 376(9747): 1186-93, 2010 Oct 02.
Artigo em Inglês | MEDLINE | ID: mdl-20709386

RESUMO

Substantial inequalities exist in cancer survival rates across countries. In addition to prevention of new cancers by reduction of risk factors, strategies are needed to close the gap between developed and developing countries in cancer survival and the effects of the disease on human suffering. We challenge the public health community's assumption that cancers will remain untreated in poor countries, and note the analogy to similarly unfounded arguments from more than a decade ago against provision of HIV treatment. In resource-constrained countries without specialised services, experience has shown that much can be done to prevent and treat cancer by deployment of primary and secondary caregivers, use of off-patent drugs, and application of regional and global mechanisms for financing and procurement. Furthermore, several middle-income countries have included cancer treatment in national health insurance coverage with a focus on people living in poverty. These strategies can reduce costs, increase access to health services, and strengthen health systems to meet the challenge of cancer and other diseases. In 2009, we formed the Global Task Force on Expanded Access to Cancer Care and Control in Developing Countries, which is composed of leaders from the global health and cancer care communities, and is dedicated to proposal, implementation, and evaluation of strategies to advance this agenda.


Assuntos
Antineoplásicos/economia , Antineoplásicos/uso terapêutico , Países em Desenvolvimento/economia , Política de Saúde , Acessibilidade aos Serviços de Saúde/economia , Neoplasias , Pobreza , Colômbia , Detecção Precoce de Câncer , Saúde Global , Haiti , Acessibilidade aos Serviços de Saúde/normas , Acessibilidade aos Serviços de Saúde/tendências , Necessidades e Demandas de Serviços de Saúde , Vacinas contra Hepatite B/administração & dosagem , Humanos , Incidência , Renda , Cobertura do Seguro , Seguro Saúde , Jordânia , Malaui , Programas de Rastreamento , México , Neoplasias/diagnóstico , Neoplasias/economia , Neoplasias/epidemiologia , Neoplasias/mortalidade , Neoplasias/prevenção & controle , Neoplasias/terapia , Vacinas contra Papillomavirus/administração & dosagem , Saúde Pública , Fatores de Risco , Ruanda , Abandono do Hábito de Fumar , Fatores Socioeconômicos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA